SENTI BIO

Senti Bio is a clinical-stage company that has built a synthetic biology platform that enables us to program next-generation cell and gene therapies with Gene Circuits. Our lead product candidates utilize off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells outfitted with Gene Circuit technologies in several oncology indications with high unmet need.

Primary location: South San Francisco United States